Does Eco-driving Assistance (EDA) Have an Impact on Bus Driver's Health and Well-being?
Launched by CENTER FOR PRIMARY CARE AND PUBLIC HEALTH (UNISANTE), UNIVERSITY OF LAUSANNE, SWITZERLAND · Nov 12, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether an eco-driving assistance (EDA) system affects the health and well-being of professional bus drivers. The researchers want to find out if using the EDA system makes driving more stressful for bus drivers and if it changes their heart rate or how stressed they feel. They will compare the stress levels of drivers when they operate buses with and without this technology. Participants will wear a device to track their heart rate and will complete a daily questionnaire about their experience.
To join the trial, you must be an active bus driver who has been working for at least one year and is available to drive at least 30 hours per week. You should not have any medical implants or allergies that could interfere with the study. If you participate, you’ll drive both types of buses, wear a heart rate monitor, and answer questions about your daily experiences. The study is currently recruiting participants, and your involvement could help improve the understanding of how driving technology affects driver health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adult active bus driver
- • having signed the informed consent
- • having worked for at least one year as TPF bus driver
- • working at least 30 hours a week
- • no planned extended absences in the next 6 months (civil service, military service, long- term leave, retirement)
- Exclusion Criteria:
- • wearing a medical active implant (pacemaker, cardiac defibrillator, neurostimulator, other electronic implant)
- • known allergy or skin sensitivity to plasters
About Center For Primary Care And Public Health (Unisante), University Of Lausanne, Switzerland
The Center for Primary Care and Public Health (Unisanté) at the University of Lausanne, Switzerland, is a leading institution dedicated to advancing research and education in primary care and public health. With a strong emphasis on interdisciplinary collaboration, Unisanté focuses on addressing contemporary health challenges through innovative clinical trials and public health initiatives. The center is committed to improving healthcare delivery and outcomes by integrating evidence-based practices into community health strategies, ultimately contributing to the enhancement of population health and well-being in Switzerland and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Givisiez, Fribourg, Switzerland
Patients applied
Trial Officials
Irina Guseva Canu, Professor
Principal Investigator
Unisanté
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported